Bluepha
PrivateLast Round
Series B
Extension
Feb 14, 2023
Total Funding Raised
$399.2M
Company Overview
Bluepha operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B Extension round in February 2023.
Bluepha is a synthetic biotechnology company that specializes in microbial manufacturing and material innovation through the research and development of bio-engineered products and optimized cellular applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Advanced Materials, Circular Economy
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bluepha Comparables
Compare Bluepha with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PhaBuilder | 91% | |
| RWDC Industries | 91% | |
| Tianjin GreenBio Materials Co., Ltd. | 87% |
For institutional investors. Book with your work email.
Bluepha Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 14, 2023 | ||||
| Series B | Jan 10, 2022 | ||||
| Series B Extension | Aug 9, 2021 | ||||
| Series B | Feb 26, 2021 | ||||
| Series A Extension | May 26, 2020 | ||||
Series A | Nov 15, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bluepha Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Optimas Capital | Series B, Series B Extension |
| China Merchants Bank | Series B Extension |
| Industrial and Commercial Bank of China | Series B Extension |
| Shenzhen Lihe Carrier Venture Capital | Pre Seed |
| Hillhouse Investment | Series B, Series B Extension |
| Taihe Capital | Series B Extension, Series B |
| Shandong Weiqiao Venture Capital Co., Ltd. | Series B Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 128% MoM, reaching 682.
- May 22, 2025
Presented at the Inspiration Challenges final demo event.
For institutional investors. Book with your work email.
Bluepha Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bluepha's valuation, stock price, and market status.
Is Bluepha a public or private company?
Bluepha is a private company.
What is the current stock price of Bluepha?
Bluepha is a private company, so its shares have no public market price. Caplight tracks Bluepha's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bluepha worth (valuation)?
Valuation information for Bluepha is not publicly available.
Can I buy Bluepha stock?
Bluepha shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bluepha's last funding round?
Bluepha's most recent funding round was Series B Extension on February 14, 2023.
Who are the main investors in Bluepha?
Key investors in Bluepha include Shenzhen Lihe Carrier Venture Capital, Hillhouse Investment, Lightspeed China Partners, Genesis Capital, Shenzhen Leaguer Venture Capital.
Will Bluepha IPO soon?
No public IPO plans have been announced for Bluepha.
How can I track Bluepha secondary market activity?
Caplight tracks bids, offers, and trades in Bluepha's shares on secondary markets.